Bausch Health Companies (BHC) insider buying

Healthcare · Drug Manufacturers - Specialty & Generic · Market cap $2.3B

8 open-market purchases of BHC by Bausch Health Companies's executives and directors since June 2025, worth $370M in total, from SEC Form 4 filings.

The most recent: John Paulson bought $312M on August 14, 2025.

The biggest buyer over the period is John Paulson: 8 purchases, $370M.

By year

YearPurchasesValue
20258$370M

Biggest buyers

InsiderBuysValue
John Paulson
8$370M

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Aug 14, 2025 John Paulson
34,721,118$9.00$312M Form 4
Aug 13, 2025 John Paulson
86,409$7.06$610,048 Form 4
Aug 12, 2025 John Paulson
1,156,640$6.88$8M Form 4
Aug 11, 2025 John Paulson
2,000,000$6.35$13M Form 4
Jun 13, 2025 John Paulson
3,564,059$5.94$21M Form 4
Jun 12, 2025 John Paulson
1,005,376$5.47$5M Form 4
Jun 11, 2025 John Paulson
1,029,098$5.24$5M Form 4
Jun 10, 2025 John Paulson
754,134$5.05$4M Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for BHC.
Open BHC in Investingly

Questions

Are Bausch Health Companies insiders buying the stock?

8 open-market purchases of BHC by Bausch Health Companies's executives and directors since June 2025, worth $370M in total, from SEC Form 4 filings. The most recent: John Paulson bought $312M on August 14, 2025.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Bausch Health Companies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.